Where is Simulations Plus's headquarters?

Simulations Plus is located in Lancaster, California, United States.

Who invested in Simulations Plus?

Simulations Plus has 2 investors including U.S. Food and Drug Administration And National Institutes of Health.

When was the last funding round for Simulations Plus?

Simulations Plus closed its last funding round on obfuscated from a Grant round.

Who are Simulations Plus's competitors?

Alternatives and possible competitors to Simulations Plus may include Tempus, SandboxAQ, And Insilico Medicine.

How much funding has Simulations Plus raised to date?

Simulations Plus has raised obfuscated.

Simulations Plus - Financial Details

Financial Details

Highlights

Simulations Plus

is registered under the ticker

NASDAQ:SLP

. Their stock opened with

obfuscation

in its

obfuscation

IPO.

Simulations Plus

has raised a total of

obfuscation

in funding over

rounds. Their latest funding was raised on

obfuscation

from a

Grant

round.

Simulations Plus

is funded by

investors.

U.S. Food and Drug Administration

and

National Institutes of Health

are the most recent investors.

Simulations Plus

has acquired

organizations. Their most recent acquisition was

Pro-ficiency

obfuscation

. They acquired

Pro-ficiency

for

obfuscation

Stock Symbol

NASDAQ:SLP

Funding Rounds

Total Funding Amount

obfuscation

Lead Investors

Investors

IPO & Stock Price

Stock Symbol

NASDAQ:SLP

Money Raised at IPO

obfuscation

IPO Share Price

obfuscation

IPO Date

obfuscation

Simulations Plus

is registered under the ticker

NASDAQ:SLP

. Their stock opened with

obfuscation

in its

obfuscation

IPO.

M&A Details

Simulations Plus

was acquired by

Altaris Capital Partners

for

obfuscation

. This deal was done in

Cash

Transaction Name

Simulations Plus acquired by Altaris Capital Partners

Acquired by

Altaris Capital Partners

Announced Date

obfuscation

Price

obfuscation

Funding Rounds

Number of Funding Rounds

Total Funding Amount

obfuscation

Simulations Plus

has raised a total of

obfuscation

in funding over

rounds. Their latest funding was raised on

obfuscation

from a

Grant

round.

Which funding types raised the most money?

How much funding has this organization raised over time?

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Simulations Plus	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Simulations Plus	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Simulations Plus	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Simulations Plus	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Simulations Plus	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant

Investors

Number of Lead Investors

Number of Investors

Simulations Plus

is funded by

investors.

U.S. Food and Drug Administration

and

National Institutes of Health

are the most recent investors.

Which investors participated in the most funding rounds?

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
U.S. Food and Drug Administration	Yes	Grant - Simulations Plus	—
U.S. Food and Drug Administration	Yes	Grant - Simulations Plus	—
U.S. Food and Drug Administration	Yes	Grant - Simulations Plus	—
U.S. Food and Drug Administration	Yes	Grant - Simulations Plus	—
U.S. Food and Drug Administration	Yes	Grant - Simulations Plus	—

Acquisitions

Number of Acquisitions

Simulations Plus

has acquired

organizations. Their most recent acquisition was

Pro-ficiency

obfuscation

. They acquired

Pro-ficiency

for

obfuscation

Which types of acquisition does this organization make most frequently?

Acquiree Name	Announced Date	Price	Transaction Name
Pro-ficiency	obfuscated obfuscation	obfuscated obfuscation	Pro-ficiency acquired by Simulations Plus
Immunetrics	obfuscated obfuscation	obfuscated obfuscation	Immunetrics acquired by Simulations Plus
Lixoft	obfuscated obfuscation	obfuscated obfuscation	Lixoft acquired by Simulations Plus
DILIsym Services	obfuscated obfuscation	obfuscated obfuscation	DILIsym Services acquired by Simulations Plus
Cognigen	obfuscated obfuscation	obfuscated obfuscation	Cognigen acquired by Simulations Plus
Bioreason	obfuscated obfuscation	obfuscated obfuscation	Bioreason acquired by Simulations Plus